Vv. Yakushkin et An. Orekhov, EFFECTS OF CALCIUM-ANTAGONISTS ON CHOLESTEROL-METABOLISM IN HUMAN AORTIC INTIMAL CELLS AND IN MOUSE P388D1 MACROPHAGES, Biochemistry, 57(11), 1992, pp. 1168-1174
Effects of verapamil and nifedipine on total cholesterol concentration
in and accumulation by human aortic intimal smooth muscle cell and P3
88D1 macrophages were investigated The synthesis and hydrolysis of cho
lesterol esters in these cells were also studied Both calcium antagoni
sts reduced the content of total cholesterol in the cells derived from
the sites of atherosclerotic lesions of human aortic intima by 25-40%
but did not affect the cholesterol content in normal aortic intimal c
ells or P388D1 cells. Verapamil and nifedipine (2.10(-5) M) abolished
the accumulation of cholesterol induced in both cell types by atheroge
nic sera or atherogenic low-density lipoproteins. Both calcium antagon
ists produced 2- to 3-fold inhibitions in the synthesis of cholesterol
esters by aortic intimal cells (at concentrations above 10(-5) M) and
in P388D1 macrophages (at concentrations above 10(-6) M). At 2.10(-5)
M, both antagonists activated hydrolysis of cholesterol esters by bot
h cell types. Bay K8644, a calcium channel agonist, did not affect the
syntheses of cholesterol esters, nor did it abolish the inhibitory ac
tion of the calcium antagonists. Propranolol, a beta-blocker which pro
motes the accumulation of cholesterol in intimal cell, inhibited both
the synthesis and the hydrolysis of cholesterol esters in the aortic i
ntimal cells. Our results suggest that the antiatherogenic properties
of calcium antagonists observed in experimental and clinical tests are
due to their ability to reduce cellular levels of cholesterol, an act
ion primarily mediated by activation of the cellular hydrolysis of cho
lesterol esters.